Our Company
Our <u>Company</u>

Who we are

Our team is driven to overcome the current challenges of treating people living with severe neurological disorders. We have deep experience in genetic therapy research and development, cerebrospinal fluid (CSF) biofluid dynamics, bioengineering, and chemistry, manufacturing and controls (CMC). We collaborate to translate innovative science into significant therapeutic advancements for those most in need.


What we do

Alcyone is pioneering next-generation intra-CSF (cerebrospinal fluid) CNS precision gene-based therapeutics for complex neurological conditions. We integrate innovations in neuroscience, precision intra-CSF dosing and delivery, and manufacturing to deliver transformative therapies to patients

Our Founding

Alcyone was established in 2012 on the premise that better dosing & delivery is needed to effectively treat complex neurological disorders. Alcyone built a team to overcome this complexity by harnessing the movement of CSF, engineering novel gene-based therapeutics, and revolutionizing the manufacturing of these components for world-class clinical application.

Lowell, Massachusetts
Alcyone Corporate Headquarters
Our corporate headquarters are located in Lowell, MA, just a few miles from the epicenter of US biotechnology innovation.
Columbus, Ohio
Gene Therapy Development Center
Our cutting-edge gene-based therapeutics are developed in partnership with The Abigail Wexner Research Institute at Nationwide Children’s Hospital in Columbus, OH.
Moscow, Idaho
Falcon™ Innovation Center
The scientists developing the Falcon™ Precision Delivery System work out of our laboratory in Moscow, ID, and in collaboration with our partners at the University of Idaho.
Lowell, Massachusetts Columbus, Ohio Moscow, Idaho map

Our Locations

The Alcyone team is pioneering next-generation precision gene-based therapeutics designed to transform the lives of people living with complex neurological conditions. Explore the map to learn more about our locations.